About Eclipse Bioinnovations
Eclipse Bioinnovations is a private company based in San Diego, California. It has reported $16,855,910 raised in two offerings on Form D since September 2021. Its chief executive is Peter Chu.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 2025 | Nov 20, 2025 | $4,905,886of $7.2M target | 7 | $700K | EquityRule 506(b) | Form D ↗ |
| Aug 27, 2021 | Sep 10, 2021 | $11,950,024of $14.9M target | 10 | $1.1M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $16,855,910 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Eclipse Bioinnovations's Form D filed Nov 20, 2025.
PC
Peter Chu
Chief Executive Officer and director
DV
Daniel Vasella
Director
EW
Edmond Wong
Director
EY
Eugene Yeo
Director
Earlier filings also listed Hallie Kuhn (director, last listed Sep 2021) and Eric Van Nostrand (director, last listed Sep 2021).